Landmark survival as an end-point for trials in critically ill patients – comparison of alternative durations of follow-up: an exploratory analysis

INTRODUCTION: Interventional ICU trials have followed up patients for variable duration. However, the optimal duration of follow-up for the determination of mortality endpoint in such trials is uncertain. We aimed to determine the most logical and practical mortality end-point in clinical trials of...

Descripción completa

Detalles Bibliográficos
Autores principales: Taori, Gopal, Ho, Kwok M, George, Carol, Bellomo, Rinaldo, Webb, Steven AR, Hart, Graeme K, Bailey, Michael J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750185/
https://www.ncbi.nlm.nih.gov/pubmed/19653888
http://dx.doi.org/10.1186/cc7988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750185/
https://www.ncbi.nlm.nih.gov/pubmed/19653888
http://dx.doi.org/10.1186/cc7988

Ejemplares similares